Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Leyuan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Nanoparticles, Proteolysis, Drug Delivery Systems, Proteins. Die Arbeit nennt 207 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Research Project for Anhui Universities, Key Project for Cultivating Excellent Young Teachers in Anhui Province.
Abstract (Originalsprache)
Targeted protein degradation (TPD) has fundamentally redefined pharmacological intervention, shifting from classical occupancy‐driven inhibition to event‐driven elimination of undruggable pathogenic proteins, holding great promise for treating various intractable diseases. Although heterobifunctional degraders and molecular glues show immense therapeutic promise, their clinical translation is hindered by pharmacokinetic and pharmacodynamic disconnects, including violation of Lipinski's Rule of Five (Ro5) and autoinhibitory thermodynamics known as the hook effect. Nanoparticle‐based delivery systems offer a feasible solution that goes beyond passive solubilization. This review provides a comprehensive evaluation of advanced nanocarriers as spatiotemporal kinetic orchestrators, highlighting their capacity for active and precise therapeutic applications. In this review, we summarize recent progress in nanoparticle‐based TPD delivery strategies, outlining TPD molecular pathways and diverse nanocarriers for efficient delivery of TPD agents, including liposomes, polymeric nanoparticles, micelles, DNA nanostructures, inorganic nanomaterials, and biological carriers. Furthermore, the mechanisms, targeting strategies, preclinical efficacy, biological barriers, and optimization strategies of these works are detailed. Finally, we propose two solutions, namely localized zero‐order release platforms and engineered living vectors, with the potential to bypass physiological barriers and promote the clinical translation of TPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Medical University, Hefei, China.
- State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials Ministry of Education, College of Chemistry, Nankai University, Tianjin, China.
ORCID-Profile: Leyuan Wang, Jianhui Yang, Yang Liu, Qi Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Research Project for Anhui Universities
- Key Project for Cultivating Excellent Young Teachers in Anhui Province
Zitieren
APA
Wang, L., Yang, J., Liu, Y., & Liu, Q. (2026). Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71752
Vancouver
Wang L, Yang J, Liu Y, Liu Q. Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71752
BibTeX
@article{Wang2026,
author = {Wang, Leyuan and Yang, Jianhui and Liu, Yang and Liu, Qi},
title = {Nanoparticle‐Based Delivery Strategies for Targeted Protein Degradation},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71752}
}
EUVIMED